Pleuroparenchymal fibroelastosis - clinical analysis of 22 cases

J. Pires Parreira (Guarda, Portugal), C. Santos (Guarda, Portugal), M. Oliveira (Guarda, Portugal), N. Melo (Porto, Portugal), P. Mota (Porto, Portugal), H. Bastos (Porto, Portugal), J. Pereira (Porto, Portugal), C. Souto Moura (Porto, Portugal), A. Morais (Porto, Portugal)

Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Pires Parreira (Guarda, Portugal), C. Santos (Guarda, Portugal), M. Oliveira (Guarda, Portugal), N. Melo (Porto, Portugal), P. Mota (Porto, Portugal), H. Bastos (Porto, Portugal), J. Pereira (Porto, Portugal), C. Souto Moura (Porto, Portugal), A. Morais (Porto, Portugal). Pleuroparenchymal fibroelastosis - clinical analysis of 22 cases. 3678

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pleuroparenchymal fibroelastosis: report of 4 cases
Source: International Congress 2017 – Rare diseases
Year: 2017

Prognostic and clinical value of cluster analysis of idiopathic pleuroparenchymal fibroelastosis phenotypes
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019



Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?
Source: Eur Respir J 2015; 45: 1183-1186
Year: 2015


Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
Source: Eur Respir J 2012; 40: 377-385
Year: 2012



Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018

Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019


Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


The health status in idiopathic pleuroparenchymal fibroelastosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017

Clinical relevance of pulmonary amyloidosis: an analysis of 76 autopsy-derived cases
Source: Eur Respir J , 49 (2) 1602313; DOI: 10.1183/13993003.02313-2016
Year: 2017


Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?
Source: Eur Respir J 2013; 41: 243-245
Year: 2013


The significance of serum biomarkers as predictive factors for the clinical course of idiopathic pleuroparenchymal fibroelastosis (IPPFE)
Source: International Congress 2017 – Rare diseases
Year: 2017


Four cases of clinical analysis with Takotsubo cardiomyopathy associated with bronchoscopy
Source: International Congress 2017 – Bronchoscopy: from stents to practical tips and tricks
Year: 2017


Clinical features and outcome of pulmonary carcinoid - a 16 years review
Source: Eur Respir J 2002; 20: Suppl. 38, 77s
Year: 2002

Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?
Source: Eur Respir J 2014; 44: 289-296
Year: 2014


Clinical investigation of idiopathic pleuroparenchymal fibroelastosis cases diagnosed by radiologic findings and fibroelastosis obtained by TBLB
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014


Prevalence of pleuroparenchymal fibroelastosis (PPFE): A retrospective single-centre case study
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




Predicting factors for mortality in patients with pleuroparenchymal fibroelastosis
Source: International Congress 2017 – Rare diseases
Year: 2017


Clinical value of mediastinoscopy in the diagnosis of sarcoidosis: an analysis of 68 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 175s
Year: 2004

Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Source: International Congress 2017 – ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Year: 2017